Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.45 |
| ▸ | TSHR | P16473 | 3/20 | 0.45 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.45 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.45 |
| ▸ | HPGD | P15428 | 3/20 | 0.45 |
| ▸ | CASP1 | P29466 | 3/20 | 0.45 |
| ▸ | CASP7 | P55210 | 2/20 | 0.45 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.45 |
| ▸ | TP53 | P04637 | 1/20 | 0.45 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.45 |
| ▸ | ATM | Q13315 | 1/20 | 0.45 |
| ▸ | ENPP1 | P22413 | 2/20 | 0.41 |
| ▸ | TNF | P01375 | 1/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.38 |
| ▸ | MAPT | P10636 | 2/20 | 0.38 |
| ▸ | MEN1 | O00255 | 2/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.38 |
| ▸ | MPI | P34949 | 1/20 | 0.38 |
| ▸ | CES1 | P23141 | 2/20 | 0.38 |
| ▸ | CES2 | O00748 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30155046 | 0.86 | ALDH1A1 (0.50) | ALDH1A1TSHRMAPK1HSD17B10HPGD | |
| SCHEMBL503284 | 0.86 | ALDH1A1 (0.50) | ALDH1A1TSHRMAPK1HSD17B10HPGD | |
| SCHEMBL12071292 | 0.86 | ALDH1A1 (0.42) | ALDH1A1TSHRMAPK1HSD17B10HPGD | |
| SCHEMBL728324 | 0.84 | ALDH1A1 (0.56) | ALDH1A1TSHRMAPK1HSD17B10HPGD | |
| SCHEMBL2158220 | 0.83 | ALDH1A1 (0.47) | ALDH1A1TSHRMAPK1HSD17B10HPGD | |
| SCHEMBL2348758 | 0.82 | ALDH1A1 (0.39) | ALDH1A1TSHRMAPK1HSD17B10HPGD | |
| SCHEMBL14680392 | 0.81 | ALDH1A1 (0.37) | ALDH1A1TSHRMAPK1HSD17B10HPGD | |
| SCHEMBL16859291 | 0.80 | ALDH1A1 (0.44) | ALDH1A1TSHRMAPK1HSD17B10HPGD | |
| SCHEMBL76389 | 0.80 | ALDH1A1 (0.44) | ALDH1A1TSHRMAPK1HSD17B10HPGD | |
| SCHEMBL14680405 | 0.79 | ALDH1A1 (0.37) | ALDH1A1TSHRMAPK1HSD17B10HPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7732652-B2 | Perylene derivative synthesis process, perylene derivative and organic EL device | TDK CORPORATION (JP) | 2010-06-08 | — | — | US | disclosed |
| US-7318965-B2 | Perylene derivative synthesis process, perylene derivative and organic EL device | TDK CORPORATION (JP) | 2008-01-15 | — | — | US | disclosed |
| US-20050054852-A1 | Perylene derivative synthesis process, perylene derivative and organic EL device | TDK CORPORATION (JP) | 2005-03-10 | — | — | US | disclosed |
| US-20030137241-A1 | Perylene derivative synthesis process, perylene derivative and organic EL device | TDK CORPORATION (JP) | 2003-07-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030137241-A1 | Perylene derivative synthesis process, perylene derivative and organic EL device | CPNE4, EED, ELOC | ALDH1A1 1480/4885TSHR 4817/4885MAPK1 2346/4885 |
| US-20050054852-A1 | Perylene derivative synthesis process, perylene derivative and organic EL device | ENY2, SCO2, AOC3 | ALDH1A1 1538/4885TSHR 2103/4885MAPK1 1446/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.